世界のCD28(抗体)市場規模・現状・予測2021-2027

【英語タイトル】Global CD28(Antibody) Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1164)・商品コード:QY21APR1164
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥998,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、CD28(抗体)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(95%以上、99%以上、その他)、用途別市場規模(バイオ製薬会社、病院、生物科学研究機関、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・CD28(抗体)の市場動向
・企業の競争状況、市場シェア
・CD28(抗体)の種類別市場規模(95%以上、99%以上、その他)
・CD28(抗体)の用途別市場規模(バイオ製薬会社、病院、生物科学研究機関、その他)
・CD28(抗体)の北米市場規模2016-2027(アメリカ、カナダ)
・CD28(抗体)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・CD28(抗体)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・CD28(抗体)の中南米市場規模2016-2027(メキシコ、ブラジル)
・CD28(抗体)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Thermo Fisher Scientific、R&D Systems、Bio-Rad、Lifespan Biosciences、Abbexa Ltd、Boster Bio、Aviva Systems Biology、Biobyt、Genetex、ProteoGenix)
・結論
【レポートの概要】

Market Analysis and Insights: Global CD28(Antibody) Market
The global CD28(Antibody) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CD28(Antibody) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CD28(Antibody) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CD28(Antibody) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CD28(Antibody) market.

Global CD28(Antibody) Scope and Market Size
CD28(Antibody) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CD28(Antibody) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Above 95%
Above 99%
Others

Segment by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
R&D Systems
Bio-Rad
Lifespan Biosciences
Abbexa Ltd
Boster Bio
Aviva Systems Biology
Biobyt
Genetex

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CD28(Antibody) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Above 95%
1.2.3 Above 99%
1.2.4 Others
1.3 Market by Application
1.3.1 Global CD28(Antibody) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CD28(Antibody) Market Perspective (2016-2027)
2.2 CD28(Antibody) Growth Trends by Regions
2.2.1 CD28(Antibody) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CD28(Antibody) Historic Market Share by Regions (2016-2021)
2.2.3 CD28(Antibody) Forecasted Market Size by Regions (2022-2027)
2.3 CD28(Antibody) Industry Dynamic
2.3.1 CD28(Antibody) Market Trends
2.3.2 CD28(Antibody) Market Drivers
2.3.3 CD28(Antibody) Market Challenges
2.3.4 CD28(Antibody) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CD28(Antibody) Players by Revenue
3.1.1 Global Top CD28(Antibody) Players by Revenue (2016-2021)
3.1.2 Global CD28(Antibody) Revenue Market Share by Players (2016-2021)
3.2 Global CD28(Antibody) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CD28(Antibody) Revenue
3.4 Global CD28(Antibody) Market Concentration Ratio
3.4.1 Global CD28(Antibody) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CD28(Antibody) Revenue in 2020
3.5 CD28(Antibody) Key Players Head office and Area Served
3.6 Key Players CD28(Antibody) Product Solution and Service
3.7 Date of Enter into CD28(Antibody) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CD28(Antibody) Breakdown Data by Type
4.1 Global CD28(Antibody) Historic Market Size by Type (2016-2021)
4.2 Global CD28(Antibody) Forecasted Market Size by Type (2022-2027)

5 CD28(Antibody) Breakdown Data by Application
5.1 Global CD28(Antibody) Historic Market Size by Application (2016-2021)
5.2 Global CD28(Antibody) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CD28(Antibody) Market Size (2016-2027)
6.2 North America CD28(Antibody) Market Size by Type
6.2.1 North America CD28(Antibody) Market Size by Type (2016-2021)
6.2.2 North America CD28(Antibody) Market Size by Type (2022-2027)
6.2.3 North America CD28(Antibody) Market Size by Type (2016-2027)
6.3 North America CD28(Antibody) Market Size by Application
6.3.1 North America CD28(Antibody) Market Size by Application (2016-2021)
6.3.2 North America CD28(Antibody) Market Size by Application (2022-2027)
6.3.3 North America CD28(Antibody) Market Size by Application (2016-2027)
6.4 North America CD28(Antibody) Market Size by Country
6.4.1 North America CD28(Antibody) Market Size by Country (2016-2021)
6.4.2 North America CD28(Antibody) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe CD28(Antibody) Market Size (2016-2027)
7.2 Europe CD28(Antibody) Market Size by Type
7.2.1 Europe CD28(Antibody) Market Size by Type (2016-2021)
7.2.2 Europe CD28(Antibody) Market Size by Type (2022-2027)
7.2.3 Europe CD28(Antibody) Market Size by Type (2016-2027)
7.3 Europe CD28(Antibody) Market Size by Application
7.3.1 Europe CD28(Antibody) Market Size by Application (2016-2021)
7.3.2 Europe CD28(Antibody) Market Size by Application (2022-2027)
7.3.3 Europe CD28(Antibody) Market Size by Application (2016-2027)
7.4 Europe CD28(Antibody) Market Size by Country
7.4.1 Europe CD28(Antibody) Market Size by Country (2016-2021)
7.4.2 Europe CD28(Antibody) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CD28(Antibody) Market Size (2016-2027)
8.2 Asia-Pacific CD28(Antibody) Market Size by Type
8.2.1 Asia-Pacific CD28(Antibody) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CD28(Antibody) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CD28(Antibody) Market Size by Type (2016-2027)
8.3 Asia-Pacific CD28(Antibody) Market Size by Application
8.3.1 Asia-Pacific CD28(Antibody) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CD28(Antibody) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CD28(Antibody) Market Size by Application (2016-2027)
8.4 Asia-Pacific CD28(Antibody) Market Size by Region
8.4.1 Asia-Pacific CD28(Antibody) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CD28(Antibody) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CD28(Antibody) Market Size (2016-2027)
9.2 Latin America CD28(Antibody) Market Size by Type
9.2.1 Latin America CD28(Antibody) Market Size by Type (2016-2021)
9.2.2 Latin America CD28(Antibody) Market Size by Type (2022-2027)
9.2.3 Latin America CD28(Antibody) Market Size by Type (2016-2027)
9.3 Latin America CD28(Antibody) Market Size by Application
9.3.1 Latin America CD28(Antibody) Market Size by Application (2016-2021)
9.3.2 Latin America CD28(Antibody) Market Size by Application (2022-2027)
9.3.3 Latin America CD28(Antibody) Market Size by Application (2016-2027)
9.4 Latin America CD28(Antibody) Market Size by Country
9.4.1 Latin America CD28(Antibody) Market Size by Country (2016-2021)
9.4.2 Latin America CD28(Antibody) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CD28(Antibody) Market Size (2016-2027)
10.2 Middle East & Africa CD28(Antibody) Market Size by Type
10.2.1 Middle East & Africa CD28(Antibody) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CD28(Antibody) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CD28(Antibody) Market Size by Type (2016-2027)
10.3 Middle East & Africa CD28(Antibody) Market Size by Application
10.3.1 Middle East & Africa CD28(Antibody) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CD28(Antibody) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CD28(Antibody) Market Size by Application (2016-2027)
10.4 Middle East & Africa CD28(Antibody) Market Size by Country
10.4.1 Middle East & Africa CD28(Antibody) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CD28(Antibody) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CD28(Antibody) Introduction
11.1.4 Thermo Fisher Scientific Revenue in CD28(Antibody) Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems CD28(Antibody) Introduction
11.2.4 R&D Systems Revenue in CD28(Antibody) Business (2016-2021)
11.2.5 R&D Systems Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad CD28(Antibody) Introduction
11.3.4 Bio-Rad Revenue in CD28(Antibody) Business (2016-2021)
11.3.5 Bio-Rad Recent Development
11.4 Lifespan Biosciences
11.4.1 Lifespan Biosciences Company Details
11.4.2 Lifespan Biosciences Business Overview
11.4.3 Lifespan Biosciences CD28(Antibody) Introduction
11.4.4 Lifespan Biosciences Revenue in CD28(Antibody) Business (2016-2021)
11.4.5 Lifespan Biosciences Recent Development
11.5 Abbexa Ltd
11.5.1 Abbexa Ltd Company Details
11.5.2 Abbexa Ltd Business Overview
11.5.3 Abbexa Ltd CD28(Antibody) Introduction
11.5.4 Abbexa Ltd Revenue in CD28(Antibody) Business (2016-2021)
11.5.5 Abbexa Ltd Recent Development
11.6 Boster Bio
11.6.1 Boster Bio Company Details
11.6.2 Boster Bio Business Overview
11.6.3 Boster Bio CD28(Antibody) Introduction
11.6.4 Boster Bio Revenue in CD28(Antibody) Business (2016-2021)
11.6.5 Boster Bio Recent Development
11.7 Aviva Systems Biology
11.7.1 Aviva Systems Biology Company Details
11.7.2 Aviva Systems Biology Business Overview
11.7.3 Aviva Systems Biology CD28(Antibody) Introduction
11.7.4 Aviva Systems Biology Revenue in CD28(Antibody) Business (2016-2021)
11.7.5 Aviva Systems Biology Recent Development
11.8 Biobyt
11.8.1 Biobyt Company Details
11.8.2 Biobyt Business Overview
11.8.3 Biobyt CD28(Antibody) Introduction
11.8.4 Biobyt Revenue in CD28(Antibody) Business (2016-2021)
11.8.5 Biobyt Recent Development
11.9 Genetex
11.9.1 Genetex Company Details
11.9.2 Genetex Business Overview
11.9.3 Genetex CD28(Antibody) Introduction
11.9.4 Genetex Revenue in CD28(Antibody) Business (2016-2021)
11.9.5 Genetex Recent Development
11.10 ProteoGenix
11.10.1 ProteoGenix Company Details
11.10.2 ProteoGenix Business Overview
11.10.3 ProteoGenix CD28(Antibody) Introduction
11.10.4 ProteoGenix Revenue in CD28(Antibody) Business (2016-2021)
11.10.5 ProteoGenix Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CD28(Antibody) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Above 95%
Table 3. Key Players of Above 99%
Table 4. Key Players of Others
Table 5. Global CD28(Antibody) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CD28(Antibody) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global CD28(Antibody) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global CD28(Antibody) Market Share by Regions (2016-2021)
Table 9. Global CD28(Antibody) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global CD28(Antibody) Market Share by Regions (2022-2027)
Table 11. CD28(Antibody) Market Trends
Table 12. CD28(Antibody) Market Drivers
Table 13. CD28(Antibody) Market Challenges
Table 14. CD28(Antibody) Market Restraints
Table 15. Global CD28(Antibody) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global CD28(Antibody) Market Share by Players (2016-2021)
Table 17. Global Top CD28(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD28(Antibody) as of 2020)
Table 18. Ranking of Global Top CD28(Antibody) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by CD28(Antibody) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CD28(Antibody) Product Solution and Service
Table 22. Date of Enter into CD28(Antibody) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global CD28(Antibody) Revenue Market Share by Type (2016-2021)
Table 26. Global CD28(Antibody) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global CD28(Antibody) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global CD28(Antibody) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global CD28(Antibody) Revenue Market Share by Application (2016-2021)
Table 30. Global CD28(Antibody) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global CD28(Antibody) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America CD28(Antibody) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America CD28(Antibody) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America CD28(Antibody) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America CD28(Antibody) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America CD28(Antibody) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe CD28(Antibody) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe CD28(Antibody) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe CD28(Antibody) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe CD28(Antibody) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe CD28(Antibody) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific CD28(Antibody) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific CD28(Antibody) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific CD28(Antibody) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CD28(Antibody) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific CD28(Antibody) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America CD28(Antibody) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America CD28(Antibody) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America CD28(Antibody) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America CD28(Antibody) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America CD28(Antibody) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa CD28(Antibody) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa CD28(Antibody) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa CD28(Antibody) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa CD28(Antibody) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CD28(Antibody) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa CD28(Antibody) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific CD28(Antibody) Product
Table 65. Thermo Fisher Scientific Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. R&D Systems Company Details
Table 68. R&D Systems Business Overview
Table 69. R&D Systems CD28(Antibody) Product
Table 70. R&D Systems Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 71. R&D Systems Recent Development
Table 72. Bio-Rad Company Details
Table 73. Bio-Rad Business Overview
Table 74. Bio-Rad CD28(Antibody) Product
Table 75. Bio-Rad Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 76. Bio-Rad Recent Development
Table 77. Lifespan Biosciences Company Details
Table 78. Lifespan Biosciences Business Overview
Table 79. Lifespan Biosciences CD28(Antibody) Product
Table 80. Lifespan Biosciences Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 81. Lifespan Biosciences Recent Development
Table 82. Abbexa Ltd Company Details
Table 83. Abbexa Ltd Business Overview
Table 84. Abbexa Ltd CD28(Antibody) Product
Table 85. Abbexa Ltd Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 86. Abbexa Ltd Recent Development
Table 87. Boster Bio Company Details
Table 88. Boster Bio Business Overview
Table 89. Boster Bio CD28(Antibody) Product
Table 90. Boster Bio Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 91. Boster Bio Recent Development
Table 92. Aviva Systems Biology Company Details
Table 93. Aviva Systems Biology Business Overview
Table 94. Aviva Systems Biology CD28(Antibody) Product
Table 95. Aviva Systems Biology Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 96. Aviva Systems Biology Recent Development
Table 97. Biobyt Company Details
Table 98. Biobyt Business Overview
Table 99. Biobyt Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 100. Biobyt Recent Development
Table 101. Genetex Company Details
Table 102. Genetex Business Overview
Table 103. Genetex CD28(Antibody) Product
Table 104. Genetex Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 105. Genetex Recent Development
Table 106. ProteoGenix Company Details
Table 107. ProteoGenix Business Overview
Table 108. ProteoGenix CD28(Antibody) Product
Table 109. ProteoGenix Revenue in CD28(Antibody) Business (2016-2021) & (US$ Million)
Table 110. ProteoGenix Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD28(Antibody) Market Share by Type: 2020 VS 2027
Figure 2. Above 95% Features
Figure 3. Above 99% Features
Figure 4. Others Features
Figure 5. Global CD28(Antibody) Market Share by Application: 2020 VS 2027
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Bioscience Research Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. CD28(Antibody) Report Years Considered
Figure 11. Global CD28(Antibody) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global CD28(Antibody) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global CD28(Antibody) Market Share by Regions: 2020 VS 2027
Figure 14. Global CD28(Antibody) Market Share by Regions (2022-2027)
Figure 15. Global CD28(Antibody) Market Share by Players in 2020
Figure 16. Global Top CD28(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD28(Antibody) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by CD28(Antibody) Revenue in 2020
Figure 18. Global CD28(Antibody) Revenue Market Share by Type (2016-2021)
Figure 19. Global CD28(Antibody) Revenue Market Share by Type (2022-2027)
Figure 20. North America CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America CD28(Antibody) Market Share by Type (2016-2027)
Figure 22. North America CD28(Antibody) Market Share by Application (2016-2027)
Figure 23. North America CD28(Antibody) Market Share by Country (2016-2027)
Figure 24. United States CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe CD28(Antibody) Market Share by Type (2016-2027)
Figure 28. Europe CD28(Antibody) Market Share by Application (2016-2027)
Figure 29. Europe CD28(Antibody) Market Share by Country (2016-2027)
Figure 30. Germany CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific CD28(Antibody) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific CD28(Antibody) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific CD28(Antibody) Market Share by Region (2016-2027)
Figure 40. China CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America CD28(Antibody) Market Share by Type (2016-2027)
Figure 48. Latin America CD28(Antibody) Market Share by Application (2016-2027)
Figure 49. Latin America CD28(Antibody) Market Share by Country (2016-2027)
Figure 50. Mexico CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa CD28(Antibody) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa CD28(Antibody) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa CD28(Antibody) Market Share by Country (2016-2027)
Figure 56. Turkey CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE CD28(Antibody) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 60. R&D Systems Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 61. Bio-Rad Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 62. Lifespan Biosciences Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 63. Abbexa Ltd Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 64. Boster Bio Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 65. Aviva Systems Biology Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 66. Biobyt Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 67. Genetex Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 68. ProteoGenix Revenue Growth Rate in CD28(Antibody) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

Thermo Fisher Scientific、R&D Systems、Bio-Rad、Lifespan Biosciences、Abbexa Ltd、Boster Bio、Aviva Systems Biology、Biobyt、Genetex、ProteoGenix

★調査レポート[世界のCD28(抗体)市場規模・現状・予測2021-2027] (コード:QY21APR1164)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のCD28(抗体)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆